⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Pomerantz LLP Advises Shareholders of Class Action Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Securities Fraud Class Action Filed Against MoonLake Immunotherapeutics (MLTX) - Levi & Korsinsky Reminds Investors of December 15, 2025
accessnewswire.com
MLTX
Pomerantz LLP Advises Shareholders of Class Action Filing Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Shareholders of MoonLake Immunotherapeutics (MLTX): Protect Your Rights Before December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
Pomerantz LLP Advises Shareholders of Class Action Filing Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
December 15, 2025 Deadline: Join Class Action Lawsuit Against MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky
accessnewswire.com
MLTX
Pomerantz LLP Advises Shareholders of Class Action Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Securities Lawsuit Alert: MoonLake Immunotherapeutics (MLTX) Investors - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
MLTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX